Robert L. Charnas
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 11
-
- Phenothiazines and Benzothiazines Synthesis and Activities 2
- Co-authors
- Jeremy R. Knowles (6 shared papers)Jed F. Fisher (3 shared papers)Christian Hubschwerlen (3 shared papers)Christian Oefner (2 shared papers)Klaus Gubernator (2 shared papers)F.K. Winkler (1 shared paper)J. J. Daly (1 shared paper)A. D’Arcy (1 shared paper)
- Journals
- Biochemistry (6 papers)Clinical Infectious Diseases (2 papers)The Pediatric Infectious Disease Journal (1 paper)Journal of Clinical Oncology (1 paper)The Journal of Urology (1 paper)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Robert L. Charnas
19 papers receiving 955 citations
Peers
Comparison fields: 5 of 80
- Molecular Medicine 682
- Applied Microbiology and Biotechnology 61
- Pharmacology 421
- Endocrinology 70
- Pollution 100
Countries citing papers authored by Robert L. Charnas
This map shows the geographic impact of Robert L. Charnas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Charnas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Charnas more than expected).
Fields of papers citing papers by Robert L. Charnas
This network shows the impact of papers produced by Robert L. Charnas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Charnas. The network helps show where Robert L. Charnas may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert L. Charnas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 260 | |
| 2 | 1978 | 182 | |
| 3 | 1981 | 96 | |
| 4 | 1978 | 67 | |
| 5 | 1980 | 62 | |
| 6 | 1997 | 61 | |
| 7 | 1981 | 57 | |
| 8 | 1998 | 57 | |
| 9 | 1981 | 53 | |
| 10 | 1987 | 45 | |
| 11 | 2016 | 25 | |
| 12 | 1984 | 25 | |
| 13 | 1999 | 20 | |
| 14 | 1985 | 19 | |
| 15 | 1988 | 15 | |
| 16 | 1988 | 8 | |
| 17 | 1992 | 4 | |
| 18 | 2015 | 2 | |
| 19 | 2016 | 1 | |
| 20 | 2015 | 0 |
About Robert L. Charnas
Robert L. Charnas is a scholar working on Molecular Medicine, Molecular Biology, Pharmacology, Organic Chemistry and Oncology, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (11 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Prostate Cancer Treatment and Research (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Microbial Natural Products and Biosynthesis (2 papers), Hormonal and reproductive studies (2 papers), Phenothiazines and Benzothiazines Synthesis and Activities (2 papers) and Pharmaceutical and Antibiotic Environmental Impacts (2 papers). The work is most often cited by research in Molecular Medicine (682 citations), Applied Microbiology and Biotechnology (61 citations), Pharmacology (421 citations), Endocrinology (70 citations) and Pollution (100 citations). Robert L. Charnas has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Jeremy R. Knowles, Jed F. Fisher, Christian Hubschwerlen, Christian Oefner, Klaus Gubernator, F.K. Winkler, J. J. Daly, A. D’Arcy, Scott M. Bradley and I. Goldberg. Their work appears in journals such as Biochemistry, Clinical Infectious Diseases, The Pediatric Infectious Disease Journal, Journal of Clinical Oncology and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.